APRI +13% another solid day. 10 years ago? lol. Recently, Selvaraju tells investors in a research note- The analyst raised his probability of success for Vitaros to 80% from 70% and reiterates a Buy rating on Apricus. He believes that Allergan (AGN), which has an opt-in agreement for Vitaros, may choose to acquire Apricus if the topical cream secures U.S. approval.